A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy

Multiple Sclerosis

Volumn 12, Issue 6, 2006, Pages 723-730

  Haghighi, Sara ^a   Andersen, O ^a   Nilsson, S ^a   Rydberg, L ^a   Wahlstrom J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Genome scan; Healthy family members; Linkage study; Multiple sclerosis; Quantitative trait

Indexed keywords

DNA; HLA ANTIGEN; HLA DR ANTIGEN; OLIGOCLONAL BAND;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOSOMAL DOMINANT INHERITANCE; CEREBROSPINAL FLUID ANALYSIS; CHROMOSOME 12Q; CHROMOSOME 19Q; CHROMOSOME 6P; CHROMOSOME 6Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FAMILY STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LINKAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PENETRANCE; POLYMERASE CHAIN REACTION; RELATIVE; SWEDEN; SYMPTOM;

ADULT; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 6; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HISTOCOMPATIBILITY TESTING; HUMANS; LOD SCORE; MALE; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; PEDIGREE; PHENOTYPE; QUANTITATIVE TRAIT LOCI; SWEDEN;

EID: 33846322954     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506070972     Document Type: Article

References (56)

1. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002; 104: 182-91.
2. Risch NJ. Linkage strategies for genetically complex trait. I. Multilocus models. Am J Hum Genet 1990; 46: 222-28.
3. Sadovnick A, Armstrong H, Rice G, Bulman D, Hashimoto L, Paty D. A population-based study of multiple sclerosis in twins. Update. Ann Neurol 1993; 33: 281-85.
4. Sadovnick AD, Ebers GC, Dyment DǍ, Risch NJ. Evidence for genetic basis of multiple sclerosis. Lancet 1996; 347: 1728-30.
5. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995; 377: 150-51.
6. Mumford CJ, Wood N, Keller-Wood HF, Thorpe JW, Miller D, Compston A. The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44: 11-15.
7. Thorpe JW, Mumford CJ, Compston DAS, Kendall BE, Mac Manus DG. British Isles survey of multiple sclerosis in twins. MRI. J Neurol Neurosurg Psychiatry 1994; 57: 491-96.
8. Sadovnick A, Ebers G. Genetics of multiple sclerosis. Neurol Clin 1995; 13: 99-118.
9. Robertson NP, Clayton D, Fraser M, Deans J, Compston A. Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996; 47: 347-52.
10. Compston DA. Genetic epidemiology of multiple sclerosis. Neuroepidemiology 1997; 62: 553-61.
11. Andersen O, Lygner P, Bergstrom T, Andersson M, Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993; 240: 417-22.
12. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1972; 3: 1240-41.
13. Allen M, Sandberg-Wollheim M, Sjogren K, Elrich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994; 39: 41-48.
14. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003; 72: 710-16.
15. Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J et al. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta. J Neuroimmunol 2002; 130: 194-201.
16. Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, et al. Major histocompatibility complex class II alleles and the course and the outcome of MS: a population-based study. Neurology 1998; 51: 742-47.
17. Akesson E, Oturai A, Berg J, Fredrikson S, Andersen O, Harbo HF et al. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immunol 2002; 3: 279-85.
18. Ban M, Stewart GJ, Bennetts BH, Heard R, Simmons R, Maranian M et al. A genome screen for linkage in Australian sibling-pair with multiple sclerosis. Genes Immunol 2002; 3: 464-69.
19. Broadley S. A genome screen for multiple sclerosis in Italian families. Genes Immunol 2001; 2: 205-10.
20. Corradu F. A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet 2001; 9: 621-26.
21. Ebers G, Kukay K, Bulman D, Sadovnick A, Rice GPA, Andersen C. A full genome search in multiple sclerosis. Nat Genet 1996; 13: 472-76.
22. Haines J, Ter-Minassian M, Bazky A, Gusella J, Kim D, Tenwedow H. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996; 13: 469-71.
23. Kuokkanen S, Gschwed M, Rioux JD, Daly MJ, Terwilliger JD, Tienari P et al. Genomewide scan of multiple sclerosis in Finnish multiples families. Am J Hum Genet 1997; 61: 1379-87.
24. Sawcer S, Jones H, Feakes R, Gray J, Smaldon N, Chataway J et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996; 13: 464-68.
25. Lander E, Kruglyak L. Genetic dissection of complex traits: guide-lines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-47.
26. Duquette P, Charest L. Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients. Neurology 1986; 36: 727-29.
27. Haghighi S, Andersen O, Rosengren L, Bergström T, Wahlström J, Nilsson S. Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. J Neurol Neurosurg Psychiatry 2000; 47: 61622.
28. Poser CM. The pathogenesis of MS: a critical reappraisal. Acta Neuropathol 1986; 71: 1-10.
29. Lycke J, Svennerholm. B, Hjelmqvist E, Frisen L, Badr G, Andersson A et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Neurol 1996; 243: 214-24.
30. Poser C, Paty D, Sceinberg L, MacDonald W, Davis F, Ebers G et al. New diagnosis criteria for multiple sclerosis. Ann Neurol 1983; 13: 227-31.
31. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J et al. Current protocols in molecular biology. 3rd Sprl edition ed. New York: Willy John & Sons; 1995.
32. Crowe J, Feuser P, Goergen B. Rapid nucleic acid purification for reliable PCR. J NIH Res 1993; 39: 73.
33. Olerup O, Zetterqvist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tiss Antigens 1992; 39: 225-35.
34. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker sharing statistics. Am J Hum Genet 1996; 58: 1323-37.
35. Sobel E, Sengul H, Weeks D. Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees. Hum Heredity 2001; 52: 121-31.
36. Sobel E, Papp J, Lange K. Detection and integration of genotyping errors in statistical genetics. Am J Hum Genet 2002; 70: 469-508.
37. Vitale E, Cook S, Sun R, Specchia C, Subramanian K, Rocchi M et al. Linkage analysis conditional on HLA status in large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. Hum Mol Genet 2002; 11: 295-300.
38. Dyment DA, Cader Z, Willer C, Risch NJ, Sadovnick AD, Ebers C. A multigenerational family with multiple sclerosis. Brain 2002; 125: 1474-82.
39. Goertsches R, Villoslada P, Comabella M, Montalban X, Navarro A, de la Concha Arroyo R et al. A genomic screen of Spanish multiple sclerosis patients reveals multi loci associated with disease. J Neuroimmunol 2003; 143: 124-28.
40. Harbo, H, Datta P, Oturai A, Ryder L, Sawcer S, Setakis E et al. Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients. J Neuroimmunol 2003; 143: 101-106.
41. Schmidt S, Barcellos LF, DeSombre K, Rimmler J, Lincoln R, Bucher P et al. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am J Hum Genet 2002; 70: 708-17.
42. Haines J, Bradford Y, Garcia ME, Reed AD, Neumeister E, Pericak-Vance MA et al. Multiple susceptibility loci for multiple sclerosis. Hum Mol Genet 2002; 15: 2251-56.
43. Xu C, Dai Y, Frerikson S, Hillert J. Association and linkage analysis of candidate chromosomal regions in multiple sclerosis: indication of disease genes in 12q23 and 7ptr-15. Eur J Hum Genet 1999; 7: 110-16.
44. Barcellos LF, Thomson G. Genetic analysis of multiple sclerosis in Europeans. J Neuroimmunol 2003; 143: 1-6.
45. Sawcer S, Ban M, Maranian M et al. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-67.
46. Dyment D, Sadovnick A, Willer C, Armstrong H, Cader Z, Wiltshire S et al. An extended genome scan in 442 Canadian multiple sclerosis-affected sib ship: a report from the Canadian Collaborative Study Group. Hum Mol Genet 2004; 15: 1005-15.
47. Compston DA, Batchelor JR, McDonald WI. B-lymphocyte alloantigenes associated with multiple sclerosis. Lancet 1976; 2: 1261-65.
48. Haines J, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER et al. Linkage of the MCH to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 1998; 7: 1229-34.
49. van Heel D, Satsangi J, Carey A, Jewell D. Inflammatory bowel disease: progress towards a gene. Can J Gastroenterol 2000; 14: 207-18.
50. Puzanowska B, Prokopowicz D, Ziarko S, Radziwon P, Lapinski T. The incidence of HLA DRB1*0103 in ulcerative colitis patients in north-eastern Poland. Hepatogastroenterology 2003; 50: 1436-38.
51. de la Concha E, Fernandez-Arquero M, Lopez-Nava G et al. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 2000; 119: 1491-95.
52. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Ruiz-Morales JA, Higuera L, Cutino T et al. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol 2003; 64: 119-23.
53. Silverberg MS, Mirea L, Bull SB, Murphy JE, Steinhart AH, Greenberg GR et al. A population-and family-based study of Canadian families reveals association of HLADRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 1-9.
54. Newman B, Silverberg MS, Gu X et al. CARD15 and HLA DRB1 alleles influence susceptibility and disease localisation in Crohn's disease. Am J Gastroenterol 2004; 99: 306-15.
55. Orchard T, Chua C, Ahmad T, Cheng H, Welsh K, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002; 123: 714-18.
56. Gilbert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum Immunol 2003; 64: 930-35.